Clinical Trials Logo

Brachial Plexus Block Duration clinical trials

View clinical trials related to Brachial Plexus Block Duration.

Filter by:
  • None
  • Page 1

NCT ID: NCT02629835 Completed - Clinical trials for Brachial Plexus Block Duration

Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks

Start date: January 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Dexamethasone prolong the duration of brachial plexus blocks, but the optimal route, intravenous (IV) or perineural (PN), remains controversial. This Multi-centric trial compare IV and PN dexamethasone for ultrasound-guided axillary brachial plexus blocks (AXBs). Research hypothesis is that PN modality will outlast its IV counterpart. Since analgesic duration and sensory duration can be influenced by intake of pain medications and surgical trauma to small cutaneous nerves, the investigators will select motor block duration as the main outcome.